Laboratory of Parasitic Diseases, Department of Veterinary Medicine, Federal University of Parana, Curitiba, PR, Brazil.
Vet Parasitol. 2012 Apr 19;185(1):16-24. doi: 10.1016/j.vetpar.2011.10.013. Epub 2011 Oct 18.
Avermectins and milbemycins (AM) are potent compounds against all major nematode parasites, but their continuous usage has led to the development of widespread resistance in many of the important species of ruminant and equine parasites. The exception to this has been the cyathostomins, where AM resistance was recently first reported only after decades of drug exposure. Data from a Brazilian study suggests that AM resistance has developed in cyathostomins and reports of shortened egg reappearance periods after ivermectin treatment have been published recently from USA and Germany. Thus, AM resistance in cyathostomins is an emerging worldwide concern, but there is only limited amount data on the extent of this problem. To limit the development and spread of AM-resistant cyathostomins the equine industry must implement new strategies for worm control, and the veterinary parasitology community must develop and validate improved protocols for detecting anthelmintic resistance in the field.
阿维菌素类和米尔贝肟类(AM)是对抗所有主要线虫寄生虫的有效化合物,但它们的持续使用导致许多反刍动物和马属动物寄生虫的重要物种产生了广泛的耐药性。但这种情况不适用于Cyathostomins,最近才首次报道 AM 耐药性在经历了数十年的药物暴露后才出现。来自巴西的一项研究数据表明,Cyathostomins 中已经出现了 AM 耐药性,并且最近来自美国和德国的报告显示伊维菌素治疗后的卵再次出现时间缩短。因此,Cyathostomins 中的 AM 耐药性是一个全球范围内正在出现的问题,但关于这个问题的严重程度的数据非常有限。为了限制 AM 耐药性 Cyathostomins 的发展和传播,马业必须实施新的驱虫策略,兽医寄生虫学社区必须开发和验证改进的现场驱虫剂耐药性检测方案。